Poseida Therapeutics, Inc.盘中异动早盘股价大涨5.07%报2.90美元_老虎社区_美港股上老虎

Poseida Therapeutics, Inc.盘中异动早盘股价大涨5.07%报2.90美元

市场透视11-18

北京时间2024年11月18日22时36分，Poseida Therapeutics, Inc.（PSTX.us）股票出现异动，股价大幅拉升5.07%。截至发稿，该股报2.90美元/股，成交量3.2531万股，换手率0.03%，振幅7.97%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-4.60倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2484676732?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-18 22:36","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2484676732","market":"us","top_or_hot":-1,"title":"Poseida Therapeutics, Inc.盘中异动 早盘股价大涨5.07%报2.90美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月18日22时36分，Poseida Therapeutics, Inc.（PSTX.us）股票出现异动，股价大幅拉升5.07%。截至发稿，该股报2.90美元/股，成交量3.2531万股，换手率0.03%，振幅7.97%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-4.60倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360195be48af&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Poseida Therapeutics, Inc.盘中异动 早盘股价大涨5.07%报2.90美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPoseida Therapeutics, Inc.盘中异动 早盘股价大涨5.07%报2.90美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-18 22:36 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360195be48af&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月18日22时36分，Poseida Therapeutics, Inc.（PSTX.us）股票出现异动，股价大幅拉升5.07%。截至发稿，该股报2.90美元/股，成交量3.2531万股，换手率0.03%，振幅7.97%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-4.60倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360195be48af&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PSTX","symbol_name":"Poseida Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360195be48af&s=b","article_id":"2484676732","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360195be48af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484676732","pubTimestamp":1731940561,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月18日22时36分，Poseida Therapeutics, Inc.股票出现异动，股价大幅拉升5.07%。截至发稿，该股报2.90美元/股，成交量3.2531万股，换手率0.03%，振幅7.97%。Poseida Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Poseida Therapeutics, Inc.公司简介：Poseida Therapeutics Inc是一家临床阶段的生物制药公司，致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PSTX":"Poseida Therapeutics, Inc.","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Poseida Therapeutics, Inc. shares jumped 5.07% to $2.90 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"PSTX":1},"content_text":"北京时间2024年11月18日22时36分，Poseida Therapeutics, Inc.（PSTX.us）股票出现异动，股价大幅拉升5.07%。截至发稿，该股报2.90美元/股，成交量3.2531万股，换手率0.03%，振幅7.97%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-4.60倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Poseida Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Hcw Biologics Inc.、冠科美博、Exicure, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为532.21%、244.40%、206.82%，振幅较大的相关个股有Hcw Biologics Inc.、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、冠科美博，振幅分别为67.89%、37.19%、34.31%。Poseida Therapeutics, Inc.公司简介：Poseida Therapeutics Inc是一家临床阶段的生物制药公司，致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。 它已建立了自体和同种异体嵌合抗原受体T细胞或CAR-T候选产品线，最初专注于治疗血液恶性肿瘤和实体瘤。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}